<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>GI Bleeding Study Guide - The Nursing Collective</title>
    <meta name="description" content="Comprehensive nursing study guide for GI Bleeding. Learn to differentiate upper vs lower GI bleeding, recognize hemodynamic instability, and understand endoscopy indications.">
    <link rel="canonical" href="https://thenursingcollective.pro/guides/gi-bleeding.html">
    <meta property="og:type" content="website">
    <meta property="og:url" content="https://thenursingcollective.pro/guides/gi-bleeding.html">
    <meta property="og:title" content="GI Bleeding Study Guide - The Nursing Collective">
    <meta property="og:description" content="Comprehensive nursing study guide for GI Bleeding. Learn to differentiate upper vs lower GI bleeding, recognize hemodynamic instability, and understand endoscopy indications.">
    <meta property="og:image" content="https://thenursingcollective.pro/assets/images/og-preview.png">

    <!-- Favicon -->
    <link rel="icon" type="image/x-icon" href="../favicon.ico">

    <!-- Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Outfit:wght@300;400;500;600;700&family=Source+Sans+3:wght@300;400;500;600;700&display=swap" rel="stylesheet">

    <!-- Font Awesome -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css" integrity="sha512-iecdLmaskl7CVkqkXNQ/ZH/XLlvWZOJyj7Yy7tcenmpD1ypASozpmT/E0iPtmFIB46ZmdtAc9eNBvH0H/ZpiBw==" crossorigin="anonymous" referrerpolicy="no-referrer">

    <style>
        /* ============================================
           GI BLEEDING GUIDE - ANATOMY JOURNEY LAYOUT
           Top-to-bottom organ flow format
           Regional sections (upper/lower GI)
           ============================================ */

        :root {
            --primary-color: #2E86AB;
            --primary-dark: #236b8a;
            --secondary-color: #A23B72;
            --accent-color: #f59e0b;
            --text-primary: #1f2937;
            --text-secondary: #4b5563;
            --background: #ffffff;
            --border-color: #e5e7eb;
            /* GI Bleeding-specific colors */
            --upper-gi-color: #dc2626;
            --lower-gi-color: #991b1b;
            --bleed-red: #ef4444;
            --bleed-dark: #7f1d1d;
            --stable-green: #10b981;
            --unstable-red: #dc2626;
            --warning-orange: #f59e0b;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Source Sans 3', -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
            line-height: 1.7;
            color: var(--text-primary);
            background: #f8fafc;
        }

        /* Download Bar - Fixed at top */
        .download-bar {
            position: fixed;
            top: 0;
            left: 0;
            right: 0;
            background: linear-gradient(135deg, #dc2626, #991b1b);
            color: white;
            padding: 12px 24px;
            display: flex;
            justify-content: space-between;
            align-items: center;
            z-index: 1000;
            box-shadow: 0 2px 10px rgba(0,0,0,0.2);
        }

        .download-bar-brand {
            display: flex;
            align-items: center;
            gap: 12px;
            font-weight: 600;
        }

        .download-bar-actions {
            display: flex;
            gap: 12px;
        }

        .btn-download {
            display: inline-flex;
            align-items: center;
            gap: 8px;
            padding: 10px 20px;
            background: white;
            color: var(--upper-gi-color);
            border: none;
            border-radius: 8px;
            font-weight: 600;
            font-size: 0.95rem;
            cursor: pointer;
            transition: all 0.2s ease;
            text-decoration: none;
        }

        .btn-download:hover {
            background: #fef2f2;
            transform: translateY(-1px);
        }

        .btn-back {
            display: inline-flex;
            align-items: center;
            gap: 8px;
            padding: 10px 20px;
            background: rgba(255,255,255,0.15);
            color: white;
            border: 1px solid rgba(255,255,255,0.3);
            border-radius: 8px;
            font-weight: 500;
            font-size: 0.95rem;
            cursor: pointer;
            transition: all 0.2s ease;
            text-decoration: none;
        }

        .btn-back:hover {
            background: rgba(255,255,255,0.25);
        }

        /* Document Container */
        .document-container {
            max-width: 900px;
            margin: 80px auto 40px;
            background: white;
            box-shadow: 0 4px 20px rgba(0,0,0,0.1);
        }

        /* Cover Page - Red/Maroon bleeding themed gradient */
        .cover-page {
            background: linear-gradient(135deg, #7f1d1d 0%, #dc2626 40%, #991b1b 80%, #450a0a 100%);
            color: white;
            padding: 80px 60px;
            text-align: center;
            position: relative;
            overflow: hidden;
        }

        .cover-page::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: url("data:image/svg+xml,%3Csvg width='80' height='80' viewBox='0 0 80 80' xmlns='http://www.w3.org/2000/svg'%3E%3Cg fill='none' fill-rule='evenodd'%3E%3Cg fill='%23ffffff' fill-opacity='0.04'%3E%3Cpath d='M40 40c0-11.046 8.954-20 20-20s20 8.954 20 20-8.954 20-20 20-20-8.954-20-20zM0 40c0-11.046 8.954-20 20-20s20 8.954 20 20-8.954 20-20 20S0 51.046 0 40z'/%3E%3C/g%3E%3C/g%3E%3C/svg%3E");
            opacity: 0.5;
        }

        .cover-content {
            position: relative;
            z-index: 1;
        }

        .cover-logo {
            width: 90px;
            height: 90px;
            background: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin: 0 auto 30px;
            box-shadow: 0 8px 25px rgba(0,0,0,0.3);
            padding: 15px;
        }

        .cover-logo img {
            width: 100%;
            height: 100%;
            object-fit: contain;
        }

        .cover-badge {
            display: inline-flex;
            align-items: center;
            gap: 8px;
            padding: 10px 24px;
            background: rgba(239, 68, 68, 0.3);
            border: 1px solid rgba(255,255,255,0.3);
            border-radius: 50px;
            font-size: 0.85rem;
            font-weight: 700;
            letter-spacing: 1.5px;
            text-transform: uppercase;
            margin-bottom: 24px;
        }

        .cover-badge i {
            animation: pulse 2s infinite;
        }

        @keyframes pulse {
            0%, 100% { opacity: 1; }
            50% { opacity: 0.5; }
        }

        .cover-title {
            font-family: 'Outfit', sans-serif;
            font-size: 4rem;
            font-weight: 700;
            margin-bottom: 20px;
            line-height: 1.1;
            text-shadow: 0 2px 10px rgba(0,0,0,0.2);
        }

        .cover-subtitle {
            font-size: 1.25rem;
            opacity: 0.95;
            max-width: 600px;
            margin: 0 auto 40px;
            line-height: 1.6;
        }

        .cover-stats {
            display: flex;
            justify-content: center;
            gap: 50px;
            flex-wrap: wrap;
            padding-top: 30px;
            border-top: 1px solid rgba(255,255,255,0.2);
        }

        .cover-stat {
            text-align: center;
        }

        .cover-stat .number {
            font-family: 'Outfit', sans-serif;
            font-size: 2rem;
            font-weight: 700;
        }

        .cover-stat .label {
            font-size: 0.85rem;
            opacity: 0.85;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            margin-top: 4px;
        }

        .cover-brand {
            margin-top: 50px;
            padding-top: 30px;
            border-top: 1px solid rgba(255,255,255,0.2);
            font-size: 0.95rem;
            opacity: 0.9;
        }

        /* Document Content */
        .document-content {
            padding: 60px;
        }

        /* Learning Objectives */
        .learning-objectives {
            background: linear-gradient(135deg, #fef2f2, #fecaca);
            border-radius: 16px;
            padding: 32px;
            margin-bottom: 40px;
            position: relative;
            overflow: hidden;
        }

        .learning-objectives::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(220, 38, 38, 0.1) 0%, transparent 60%);
        }

        .learning-objectives h2 {
            font-family: 'Outfit', sans-serif;
            font-size: 1.3rem;
            font-weight: 700;
            color: #991b1b;
            margin-bottom: 20px;
            display: flex;
            align-items: center;
            gap: 12px;
            position: relative;
        }

        .learning-objectives-grid {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 16px;
            position: relative;
        }

        .objective-card {
            background: white;
            border-radius: 12px;
            padding: 16px 20px;
            display: flex;
            align-items: flex-start;
            gap: 14px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        .objective-card i {
            color: var(--upper-gi-color);
            font-size: 1.1rem;
            margin-top: 2px;
            flex-shrink: 0;
        }

        .objective-card span {
            font-size: 0.98rem;
            color: var(--text-primary);
        }

        /* Sticky Navigation */
        .sticky-nav {
            background: #f8fafc;
            border: 1px solid var(--border-color);
            border-radius: 12px;
            padding: 20px;
            margin-bottom: 40px;
            position: sticky;
            top: 70px;
            z-index: 100;
        }

        .sticky-nav h3 {
            font-family: 'Outfit', sans-serif;
            font-size: 0.9rem;
            font-weight: 600;
            color: var(--text-secondary);
            text-transform: uppercase;
            letter-spacing: 1px;
            margin-bottom: 14px;
        }

        .nav-pills {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
        }

        .nav-pills a {
            display: inline-flex;
            align-items: center;
            gap: 8px;
            padding: 10px 16px;
            background: white;
            border: 1px solid var(--border-color);
            border-radius: 8px;
            color: var(--text-secondary);
            text-decoration: none;
            font-size: 0.9rem;
            font-weight: 500;
            transition: all 0.2s ease;
        }

        .nav-pills a:hover {
            background: var(--upper-gi-color);
            color: white;
            border-color: var(--upper-gi-color);
        }

        .nav-pills a i {
            font-size: 0.85rem;
        }

        /* Content Sections */
        .guide-section {
            margin-bottom: 50px;
            scroll-margin-top: 140px;
        }

        .section-header {
            display: flex;
            align-items: center;
            gap: 16px;
            margin-bottom: 24px;
            padding-bottom: 16px;
            border-bottom: 2px solid var(--border-color);
        }

        .section-number {
            display: flex;
            align-items: center;
            justify-content: center;
            width: 48px;
            height: 48px;
            background: linear-gradient(135deg, var(--upper-gi-color), var(--lower-gi-color));
            color: white;
            border-radius: 12px;
            font-family: 'Outfit', sans-serif;
            font-size: 1.3rem;
            font-weight: 700;
            flex-shrink: 0;
        }

        .section-title-group h2 {
            font-family: 'Outfit', sans-serif;
            font-size: 1.6rem;
            font-weight: 700;
            color: var(--text-primary);
            margin: 0;
        }

        .section-title-group .subtitle {
            font-size: 0.95rem;
            color: var(--text-secondary);
            margin-top: 4px;
        }

        .guide-section h3 {
            font-family: 'Outfit', sans-serif;
            font-size: 1.25rem;
            font-weight: 600;
            color: var(--text-primary);
            margin: 28px 0 14px;
        }

        .guide-section h4 {
            font-family: 'Outfit', sans-serif;
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--upper-gi-color);
            margin: 20px 0 10px;
        }

        .guide-section p {
            color: var(--text-secondary);
            font-size: 1.02rem;
            margin-bottom: 14px;
        }

        .guide-section ul, .guide-section ol {
            color: var(--text-secondary);
            margin-bottom: 16px;
            padding-left: 24px;
        }

        .guide-section li {
            margin-bottom: 8px;
        }

        .guide-section strong {
            color: var(--text-primary);
        }

        /* Anatomy Journey - Organ Flow */
        .organ-journey {
            background: linear-gradient(180deg, #fef2f2 0%, #ffffff 50%, #fef2f2 100%);
            border-radius: 16px;
            padding: 32px;
            margin: 24px 0;
            position: relative;
        }

        .organ-journey h3 {
            color: var(--bleed-dark);
            margin: 0 0 24px;
            text-align: center;
            display: flex;
            align-items: center;
            justify-content: center;
            gap: 10px;
        }

        .journey-path {
            position: relative;
            padding-left: 40px;
        }

        .journey-path::before {
            content: '';
            position: absolute;
            left: 16px;
            top: 0;
            bottom: 0;
            width: 4px;
            background: linear-gradient(180deg, var(--upper-gi-color), var(--lower-gi-color));
            border-radius: 2px;
        }

        .journey-stop {
            position: relative;
            margin-bottom: 24px;
            padding: 20px;
            background: white;
            border-radius: 12px;
            border: 1px solid var(--border-color);
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        .journey-stop::before {
            content: '';
            position: absolute;
            left: -32px;
            top: 24px;
            width: 20px;
            height: 20px;
            background: white;
            border: 4px solid var(--upper-gi-color);
            border-radius: 50%;
        }

        .journey-stop.lower::before {
            border-color: var(--lower-gi-color);
        }

        .journey-stop h4 {
            margin: 0 0 8px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .journey-stop p {
            margin: 0;
            font-size: 0.95rem;
        }

        /* Region Sections - Upper vs Lower */
        .region-comparison {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 0;
            margin: 24px 0;
            border-radius: 16px;
            overflow: hidden;
            border: 2px solid var(--border-color);
        }

        .region-section {
            padding: 0;
        }

        .region-header {
            padding: 24px;
            text-align: center;
            color: white;
        }

        .region-section.upper .region-header {
            background: linear-gradient(135deg, #dc2626, #ef4444);
        }

        .region-section.lower .region-header {
            background: linear-gradient(135deg, #7f1d1d, #991b1b);
        }

        .region-header i {
            font-size: 2.5rem;
            margin-bottom: 12px;
            display: block;
        }

        .region-header h4 {
            color: white;
            font-size: 1.3rem;
            margin: 0 0 4px;
        }

        .region-header .location {
            font-size: 0.95rem;
            opacity: 0.9;
        }

        .region-body {
            padding: 24px;
            background: white;
        }

        .region-body h5 {
            font-family: 'Outfit', sans-serif;
            font-size: 0.9rem;
            font-weight: 600;
            color: var(--text-secondary);
            text-transform: uppercase;
            letter-spacing: 0.5px;
            margin: 0 0 12px;
            padding-bottom: 8px;
            border-bottom: 1px solid var(--border-color);
        }

        .region-body h5:not(:first-child) {
            margin-top: 20px;
        }

        .region-body ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .region-body li {
            display: flex;
            align-items: flex-start;
            gap: 10px;
            padding: 8px 0;
            font-size: 0.95rem;
            color: var(--text-secondary);
        }

        .region-body li i {
            margin-top: 3px;
            flex-shrink: 0;
        }

        .region-section.upper .region-body li i { color: var(--upper-gi-color); }
        .region-section.lower .region-body li i { color: var(--lower-gi-color); }

        /* Symptom Map */
        .symptom-map {
            background: #f8fafc;
            border-radius: 16px;
            padding: 32px;
            margin: 24px 0;
            border: 1px solid var(--border-color);
        }

        .symptom-map h3 {
            color: var(--bleed-dark);
            margin: 0 0 24px;
            text-align: center;
        }

        .symptom-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 16px;
        }

        .symptom-card {
            background: white;
            border-radius: 12px;
            padding: 20px;
            text-align: center;
            border: 1px solid var(--border-color);
            transition: all 0.2s ease;
        }

        .symptom-card:hover {
            box-shadow: 0 4px 12px rgba(0,0,0,0.08);
            transform: translateY(-2px);
        }

        .symptom-icon {
            width: 50px;
            height: 50px;
            background: linear-gradient(135deg, var(--upper-gi-color), var(--lower-gi-color));
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin: 0 auto 12px;
            color: white;
            font-size: 1.3rem;
        }

        .symptom-card h5 {
            font-family: 'Outfit', sans-serif;
            font-size: 1rem;
            font-weight: 600;
            color: var(--text-primary);
            margin: 0 0 8px;
        }

        .symptom-card p {
            font-size: 0.9rem;
            color: var(--text-secondary);
            margin: 0;
            line-height: 1.4;
        }

        /* Hemodynamic Status - Stability Assessment */
        .stability-assessment {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 24px;
            margin: 24px 0;
        }

        .stability-box {
            border-radius: 16px;
            overflow: hidden;
        }

        .stability-box.stable {
            border: 2px solid var(--stable-green);
        }

        .stability-box.unstable {
            border: 2px solid var(--unstable-red);
        }

        .stability-header {
            padding: 20px;
            display: flex;
            align-items: center;
            gap: 12px;
            color: white;
        }

        .stability-box.stable .stability-header {
            background: linear-gradient(135deg, #059669, #10b981);
        }

        .stability-box.unstable .stability-header {
            background: linear-gradient(135deg, #b91c1c, #ef4444);
        }

        .stability-header i {
            font-size: 1.5rem;
        }

        .stability-header h4 {
            color: white;
            margin: 0;
            font-size: 1.1rem;
        }

        .stability-body {
            padding: 20px;
            background: white;
        }

        .stability-body ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .stability-body li {
            display: flex;
            align-items: flex-start;
            gap: 10px;
            padding: 10px 0;
            border-bottom: 1px solid var(--border-color);
            font-size: 0.95rem;
            color: var(--text-secondary);
        }

        .stability-body li:last-child {
            border-bottom: none;
        }

        .stability-body li i {
            margin-top: 3px;
            flex-shrink: 0;
        }

        .stability-box.stable .stability-body li i { color: var(--stable-green); }
        .stability-box.unstable .stability-body li i { color: var(--unstable-red); }

        /* Procedure Visual */
        .procedure-visual {
            background: linear-gradient(135deg, #fef3c7, #fde68a);
            border-radius: 16px;
            padding: 32px;
            margin: 24px 0;
        }

        .procedure-visual h3 {
            color: #92400e;
            margin: 0 0 24px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .procedure-timeline {
            display: flex;
            justify-content: space-between;
            position: relative;
            padding: 20px 0;
        }

        .procedure-timeline::before {
            content: '';
            position: absolute;
            top: 44px; /* Positioned at center of the 48px markers (24px) + 20px padding */
            left: 24px;
            right: 24px;
            height: 4px;
            background: linear-gradient(to right, var(--stable-green), var(--warning-orange), var(--upper-gi-color));
            border-radius: 2px;
        }

        .procedure-step {
            position: relative;
            text-align: center;
            flex: 1;
            padding: 0 8px;
        }

        .procedure-marker {
            width: 48px;
            height: 48px;
            background: white;
            border: 4px solid;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin: 0 auto 16px;
            position: relative;
            z-index: 1;
            font-size: 1.1rem;
        }

        .procedure-step:nth-child(1) .procedure-marker { border-color: var(--stable-green); color: var(--stable-green); }
        .procedure-step:nth-child(2) .procedure-marker { border-color: var(--warning-orange); color: var(--warning-orange); }
        .procedure-step:nth-child(3) .procedure-marker { border-color: var(--upper-gi-color); color: var(--upper-gi-color); }
        .procedure-step:nth-child(4) .procedure-marker { border-color: var(--bleed-dark); color: var(--bleed-dark); }

        .procedure-label {
            font-weight: 600;
            font-size: 0.9rem;
            color: var(--text-primary);
            line-height: 1.3;
        }

        .procedure-desc {
            font-size: 0.85rem;
            color: var(--text-secondary);
            margin-top: 6px;
        }

        /* Info Boxes */
        .info-box {
            border-radius: 12px;
            padding: 20px 24px;
            margin: 20px 0;
            display: flex;
            gap: 16px;
        }

        .info-box-icon {
            width: 44px;
            height: 44px;
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            flex-shrink: 0;
        }

        .info-box-icon i {
            font-size: 1.2rem;
            color: white;
        }

        .info-box-content {
            flex: 1;
        }

        .info-box-content h5 {
            font-family: 'Outfit', sans-serif;
            font-size: 1rem;
            font-weight: 600;
            margin: 0 0 8px;
        }

        .info-box-content p {
            margin: 0;
            font-size: 0.95rem;
            color: var(--text-secondary);
        }

        .info-box-content ul {
            margin: 8px 0 0;
            padding-left: 18px;
        }

        .info-box-content li {
            margin-bottom: 4px;
            font-size: 0.95rem;
        }

        .info-box.warning {
            background: linear-gradient(135deg, #fef2f2, #fee2e2);
            border: 1px solid #fecaca;
        }

        .info-box.warning .info-box-icon { background: linear-gradient(135deg, #ef4444, #dc2626); }
        .info-box.warning .info-box-content h5 { color: #991b1b; }

        .info-box.clinical {
            background: linear-gradient(135deg, #fffbeb, #fef3c7);
            border: 1px solid #fde68a;
        }

        .info-box.clinical .info-box-icon { background: linear-gradient(135deg, #f59e0b, #d97706); }
        .info-box.clinical .info-box-content h5 { color: #92400e; }

        .info-box.nclex {
            background: linear-gradient(135deg, #f5f3ff, #ede9fe);
            border: 1px solid #ddd6fe;
        }

        .info-box.nclex .info-box-icon { background: linear-gradient(135deg, #8b5cf6, #7c3aed); }
        .info-box.nclex .info-box-content h5 { color: #5b21b6; }

        .info-box.tip {
            background: linear-gradient(135deg, #ecfdf5, #d1fae5);
            border: 1px solid #a7f3d0;
        }

        .info-box.tip .info-box-icon { background: linear-gradient(135deg, #10b981, #059669); }
        .info-box.tip .info-box-content h5 { color: #065f46; }

        /* Tables */
        .guide-table-wrapper {
            overflow-x: auto;
            margin: 20px 0;
            border-radius: 12px;
            border: 1px solid var(--border-color);
        }

        .guide-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 0.92rem;
        }

        .guide-table thead {
            background: linear-gradient(135deg, var(--upper-gi-color), var(--lower-gi-color));
            color: white;
        }

        .guide-table th {
            padding: 14px 16px;
            text-align: left;
            font-weight: 600;
        }

        .guide-table tbody tr {
            border-bottom: 1px solid var(--border-color);
        }

        .guide-table tbody tr:hover {
            background: #f9fafb;
        }

        .guide-table td {
            padding: 14px 16px;
            color: var(--text-secondary);
        }

        .guide-table td:first-child {
            font-weight: 600;
            color: var(--text-primary);
        }

        /* Intervention Cards */
        .intervention-cards {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 16px;
            margin: 20px 0;
        }

        .intervention-card {
            background: white;
            border: 1px solid var(--border-color);
            border-radius: 12px;
            padding: 20px;
            transition: all 0.2s ease;
        }

        .intervention-card:hover {
            box-shadow: 0 4px 12px rgba(0,0,0,0.08);
            transform: translateY(-2px);
        }

        .intervention-card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 12px;
        }

        .intervention-icon {
            width: 36px;
            height: 36px;
            background: linear-gradient(135deg, var(--upper-gi-color), var(--lower-gi-color));
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            color: white;
            font-size: 1rem;
        }

        .intervention-card h5 {
            font-family: 'Outfit', sans-serif;
            font-size: 1rem;
            font-weight: 600;
            color: var(--text-primary);
            margin: 0;
        }

        .intervention-card p {
            font-size: 0.92rem;
            color: var(--text-secondary);
            margin: 0;
            line-height: 1.5;
        }

        /* Key Points Summary */
        .key-points-summary {
            background: linear-gradient(135deg, #7f1d1d, #dc2626);
            border-radius: 16px;
            padding: 32px;
            margin: 40px 0 0;
            color: white;
        }

        .key-points-summary h2 {
            font-family: 'Outfit', sans-serif;
            font-size: 1.4rem;
            margin: 0 0 24px;
            display: flex;
            align-items: center;
            gap: 12px;
            color: white;
        }

        .key-points-list {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 16px;
        }

        .key-point-item {
            background: rgba(255,255,255,0.1);
            border-radius: 12px;
            padding: 18px;
            display: flex;
            align-items: flex-start;
            gap: 14px;
            border: 1px solid rgba(255,255,255,0.1);
        }

        .key-point-item i {
            font-size: 1.2rem;
            margin-top: 2px;
            flex-shrink: 0;
        }

        .key-point-item p {
            margin: 0;
            font-size: 0.95rem;
            line-height: 1.5;
            color: rgba(255,255,255,0.95);
        }

        .key-point-item strong {
            color: white;
        }

        /* Footer */
        .document-footer {
            text-align: center;
            padding: 32px 48px;
            border-top: 1px solid var(--border-color);
            background: linear-gradient(135deg, #f8fafc, #f1f5f9);
        }

        .footer-logo {
            height: 48px;
            width: auto;
            margin-bottom: 12px;
        }

        .footer-tagline {
            font-size: 0.9rem;
            color: var(--text-secondary);
            margin-bottom: 16px;
        }

        .footer-copyright {
            font-size: 0.85rem;
            color: var(--text-secondary);
        }

        /* Print Styles */
        @page {
            margin: 0.6in 0.4in;
        }

        @media print {
            .download-bar { display: none !important; }
            .sticky-nav { position: static; }

            body {
                background: white !important;
                margin: 0 !important;
                padding: 0 !important;
            }

            .document-container {
                margin: 0 !important;
                box-shadow: none !important;
                max-width: 100% !important;
                width: 100% !important;
            }

            * {
                -webkit-print-color-adjust: exact !important;
                print-color-adjust: exact !important;
                color-adjust: exact !important;
            }

            .cover-page {
                page-break-after: always;
                break-after: page;
            }

            .info-box, .stability-box, .organ-journey, .procedure-visual, .key-points-summary {
                page-break-inside: avoid;
                break-inside: avoid;
            }

            .region-comparison { page-break-inside: avoid; break-inside: avoid; }
            .guide-table-wrapper { page-break-inside: avoid; break-inside: avoid; }

            h2, h3, h4 {
                page-break-after: avoid;
                break-after: avoid;
            }

            a { text-decoration: underline; }
        }

        /* Responsive */
        @media (max-width: 768px) {
            .download-bar {
                flex-direction: column;
                gap: 12px;
                padding: 12px 16px;
            }
            .download-bar-actions {
                width: 100%;
                justify-content: center;
            }
            .document-container { margin: 120px 10px 20px; }
            .cover-page { padding: 50px 30px; }
            .cover-title { font-size: 2.5rem; }
            .cover-stats { flex-direction: column; gap: 20px; }
            .document-content { padding: 30px 24px; }
            .learning-objectives-grid { grid-template-columns: 1fr; }
            .nav-pills { flex-direction: column; }
            .nav-pills a { justify-content: center; }
            .region-comparison { grid-template-columns: 1fr; }
            .stability-assessment { grid-template-columns: 1fr; }
            .procedure-timeline { flex-direction: column; gap: 24px; }
            .procedure-timeline::before { display: none; }
            .intervention-cards { grid-template-columns: 1fr; }
            .key-points-list { grid-template-columns: 1fr; }
            .symptom-grid { grid-template-columns: 1fr; }
            .sticky-nav { position: static; }
        }
    </style>

    <!-- Sidebar Styles (shared across all guides) -->
    <link rel="stylesheet" href="guide-sidebar.css">
    <script src="../lockscreen.js"></script>
</head>
<body data-product-id="gi-bleeding" data-guide-name="GI-Bleeding">
    <!-- Download Bar -->
    <div class="download-bar">
        <div class="download-bar-brand">
            <i class="fas fa-book-medical"></i>
            <span>The Nursing Collective Study Guide</span>
        </div>
        <div class="download-bar-actions">
            <a href="../my-resources.html" class="btn-back">
                <i class="fas fa-arrow-left"></i> Back to Resources
            </a>
            <button class="btn-download" id="download-pdf-btn">
                <i class="fas fa-file-pdf"></i> Save as PDF
            </button>
        </div>
    </div>

    <!-- Document -->
    <div class="document-container">

        <!-- Cover Page -->
        <div class="cover-page">
            <div class="cover-content">
                <div class="cover-logo">
                    <img src="../assets/images/guide-icons/gi-bleeding.webp" alt="GI Bleeding">
                </div>
                <div class="cover-badge">
                    <i class="fas fa-tint"></i>
                    Medical Emergency
                </div>
                <h1 class="cover-title">GI Bleeding</h1>
                <p class="cover-subtitle">Master the assessment and management of gastrointestinal hemorrhage. Learn to differentiate upper vs lower GI bleeding, recognize hemodynamic instability, and understand intervention priorities.</p>
                <div class="cover-stats">
                    <div class="cover-stat">
                        <div class="number">80%</div>
                        <div class="label">Stop Spontaneously</div>
                    </div>
                    <div class="cover-stat">
                        <div class="number">2-15%</div>
                        <div class="label">Mortality Rate</div>
                    </div>
                    <div class="cover-stat">
                        <div class="number">24 hrs</div>
                        <div class="label">Urgent Endoscopy</div>
                    </div>
                </div>
                <div class="cover-brand">
                    <i class="fas fa-graduation-cap"></i> The Nursing Collective | January 2026
                </div>
            </div>
        </div>

        <!-- Document Content -->
        <div class="document-content">

            <!-- Learning Objectives -->
            <section class="learning-objectives">
                <h2><i class="fas fa-bullseye"></i> Learning Objectives</h2>
                <div class="learning-objectives-grid">
                    <div class="objective-card">
                        <i class="fas fa-check-circle"></i>
                        <span>Differentiate upper GI bleeding from lower GI bleeding based on clinical presentation</span>
                    </div>
                    <div class="objective-card">
                        <i class="fas fa-check-circle"></i>
                        <span>Recognize signs of hemodynamic instability and prioritize interventions</span>
                    </div>
                    <div class="objective-card">
                        <i class="fas fa-check-circle"></i>
                        <span>Understand endoscopy indications, timing, and nursing responsibilities</span>
                    </div>
                    <div class="objective-card">
                        <i class="fas fa-check-circle"></i>
                        <span>Differentiate between melena and hematochezia and their clinical significance</span>
                    </div>
                    <div class="objective-card">
                        <i class="fas fa-check-circle"></i>
                        <span>Prioritize nursing interventions for patients with active GI hemorrhage</span>
                    </div>
                    <div class="objective-card">
                        <i class="fas fa-check-circle"></i>
                        <span>Understand blood product administration and transfusion triggers in GI bleeding</span>
                    </div>
                </div>
            </section>

            <!-- High-Yield Summary -->
            <section class="high-yield-summary" id="high-yield-summary">
                <h2><i class="fas fa-bolt"></i> High-Yield Summary â€” Review This in 60 Seconds</h2>
                <p class="high-yield-subtitle">The must-know facts from this guide, distilled for quick review.</p>
                <ul>
                    <li><strong>Upper GI bleed</strong> (above ligament of Treitz) = hematemesis (vomiting blood), coffee-ground emesis, melena (black tarry stool). <strong>Lower GI bleed</strong> = hematochezia (bright red blood per rectum).</li>
                    <li><strong>Most common causes:</strong> Upper = peptic ulcer disease (PUD), esophageal varices. Lower = diverticulosis, colorectal cancer, hemorrhoids.</li>
                    <li><strong>Esophageal varices</strong> (from portal hypertension/cirrhosis) are the most DANGEROUS upper GI bleeds â€” massive hemorrhage risk. Treat with octreotide, band ligation, balloon tamponade (Blakemore tube).</li>
                    <li><strong>Melena</strong> = upper GI bleed (blood digested by gastric acid = black/tarry). <strong>Hematochezia</strong> = usually lower GI bleed, BUT massive upper GI bleed can also cause it.</li>
                    <li><strong>Priority assessment:</strong> Hemodynamic status first! HR, BP, orthostatic changes. Tachycardia is often the FIRST sign of significant blood loss.</li>
                    <li><strong>Two large-bore IVs (16â€“18 gauge)</strong> immediately. Fluid resuscitate with crystalloids, then blood products. Type and crossmatch STAT.</li>
                    <li><strong>NGT lavage:</strong> Confirms upper GI source. Coffee-ground or bloody return = upper GI bleed. Clear or bilious return = bleeding below the pylorus.</li>
                    <li><strong>EGD (esophagogastroduodenoscopy)</strong> = gold standard for upper GI bleed diagnosis AND treatment. Colonoscopy for lower GI bleeds.</li>
                    <li><strong>PPIs (IV pantoprazole/esomeprazole)</strong> reduce rebleeding risk from peptic ulcers. Often given as continuous infusion post-EGD.</li>
                    <li><strong>Common mistake:</strong> Focusing on Hgb/Hct early in acute bleeding â€” these values DON'T drop immediately because plasma and RBCs are lost proportionally. Serial values over 6â€“24 hours show the true picture.</li>
                </ul>
                <p class="high-yield-cta">Want the full breakdown? Keep reading below.</p>
            </section>

            <!-- Navigation -->
            <nav class="sticky-nav">
                <h3>Quick Navigation</h3>
                <div class="nav-pills">
                    <a href="#anatomy"><i class="fas fa-lungs"></i> GI Anatomy</a>
                    <a href="#types"><i class="fas fa-code-branch"></i> Upper vs Lower</a>
                    <a href="#assessment"><i class="fas fa-stethoscope"></i> Assessment</a>
                    <a href="#diagnostics"><i class="fas fa-microscope"></i> Diagnostics</a>
                    <a href="#interventions"><i class="fas fa-user-nurse"></i> Interventions</a>
                    <a href="#medications"><i class="fas fa-pills"></i> Medications</a>
                </div>
            </nav>

            <!-- Section 1: GI Anatomy & Physiology -->
            <section class="guide-section" id="anatomy">
                <div class="section-header">
                    <div class="section-number">1</div>
                    <div class="section-title-group">
                        <h2>GI Tract Anatomy & Blood Supply</h2>
                        <div class="subtitle">Understanding the anatomical division</div>
                    </div>
                </div>

                <p>The gastrointestinal tract is divided into upper and lower portions by the <strong>Ligament of Treitz</strong> (suspensory ligament of the duodenum). This anatomical landmark is critical for classifying GI bleeding and guiding diagnostic and treatment approaches.</p>

                <div class="organ-journey">
                    <h3><i class="fas fa-route"></i> The GI Tract Journey</h3>
                    <div class="journey-path">
                        <div class="journey-stop">
                            <h4><i class="fas fa-teeth"></i> Esophagus</h4>
                            <p>Upper GI tract begins here. Common bleeding sources: varices (portal hypertension), Mallory-Weiss tears, esophagitis, esophageal cancer.</p>
                        </div>
                        <div class="journey-stop">
                            <h4><i class="fas fa-circle"></i> Stomach</h4>
                            <p>Most common source of UGIB. Causes: peptic ulcer disease (PUD), gastritis, gastric cancer, Dieulafoy lesions, angiodysplasia.</p>
                        </div>
                        <div class="journey-stop">
                            <h4><i class="fas fa-circle"></i> Duodenum</h4>
                            <p>Duodenal ulcers are the #1 cause of UGIB. Posterior ulcers can erode into the gastroduodenal artery causing massive hemorrhage.</p>
                        </div>
                        <div class="journey-stop" style="background: #fef3c7; border-color: var(--warning-orange);">
                            <h4><i class="fas fa-exclamation-triangle" style="color: var(--warning-orange);"></i> Ligament of Treitz</h4>
                            <p><strong>THE DIVIDING LINE!</strong> Above = Upper GI bleed. Below = Lower GI bleed. This landmark determines classification, workup, and management.</p>
                        </div>

                        <div class="florencebot-tip" id="tip-ligament-treitz">
                            <div class="florencebot-tip-header">
                                <div class="florencebot-tip-icon">
                                    <i class="fas fa-lightbulb"></i>
                                </div>
                                <span class="florencebot-tip-label">FlorenceBot Pro Tip</span>
                            </div>
                            <div class="florencebot-tip-title">Ligament of Treitz</div>
                            <div class="florencebot-tip-content">
                                <strong>This anatomical landmark is THE dividing line for GI bleeding classification!</strong> The Ligament of Treitz (also called the suspensory ligament of the duodenum) marks the junction between the duodenum and jejunum. Bleeding <strong>above</strong> this point is Upper GI Bleeding (UGIB) - typically presenting with melena (black tarry stool) or hematemesis. Bleeding <strong>below</strong> is Lower GI Bleeding (LGIB) - typically presenting with hematochezia (bright red blood). This classification determines whether the patient needs an upper endoscopy (EGD) or colonoscopy.
                            </div>
                        </div>

                        <div class="journey-stop lower">
                            <h4><i class="fas fa-circle"></i> Jejunum & Ileum</h4>
                            <p>Small bowel bleeding is rare (5% of GI bleeds). Causes: angiodysplasia, Crohn's disease, tumors, Meckel's diverticulum.</p>
                        </div>
                        <div class="journey-stop lower">
                            <h4><i class="fas fa-circle"></i> Colon</h4>
                            <p>Most common site of LGIB. Causes: diverticulosis (#1), angiodysplasia, colorectal cancer, hemorrhoids, IBD.</p>
                        </div>
                        <div class="journey-stop lower">
                            <h4><i class="fas fa-circle"></i> Rectum & Anus</h4>
                            <p>Common sources of bright red blood: hemorrhoids (internal/external), anal fissures, rectal cancer, radiation proctitis.</p>
                        </div>
                    </div>
                </div>

                <div class="info-box clinical">
                    <div class="info-box-icon">
                        <i class="fas fa-lightbulb"></i>
                    </div>
                    <div class="info-box-content">
                        <h5>Clinical Pearl: Blood Supply</h5>
                        <p>The GI tract receives approximately <strong>25% of cardiac output</strong> at rest, increasing to 35% after meals. The celiac trunk supplies the upper GI tract (foregut), the superior mesenteric artery (SMA) supplies the midgut (small bowel to mid-transverse colon), and the inferior mesenteric artery (IMA) supplies the hindgut (distal colon to rectum).</p>
                    </div>
                </div>

                <h3>Key Anatomical Considerations</h3>

                <ul>
                    <li><strong>Portal Hypertension:</strong> Causes esophageal/gastric varices via collateral circulation when portal pressure exceeds 12 mmHg</li>
                    <li><strong>Arterial Supply:</strong> GI arteries are end arteries with limited collateral flowâ€”occlusion causes ischemia</li>
                    <li><strong>Watershed Areas:</strong> Splenic flexure and rectosigmoid junction are vulnerable to ischemia</li>
                    <li><strong>Diverticula:</strong> Form at weak points where blood vessels penetrate the muscularis, explaining why diverticular bleeding is arterial</li>
                </ul>

                <div class="bottom-line">
                    <p>ðŸŽ¯ Bottom Line: The ligament of Treitz is the dividing line â€” above it = upper GI, below it = lower GI. Know the GI anatomy because the location determines the presentation, workup, and treatment approach.</p>
                </div>
            </section>

            <!-- Section 2: Upper vs Lower GI Bleeding -->
            <section class="guide-section" id="types">
                <div class="section-header">
                    <div class="section-number">2</div>
                    <div class="section-title-group">
                        <h2>Upper vs Lower GI Bleeding</h2>
                        <div class="subtitle">Key differences in presentation and causes</div>
                    </div>
                </div>

                <p>Distinguishing between upper and lower GI bleeding is essential because <strong>diagnostic workup and management differ significantly</strong>. The stool characteristics, clinical presentation, and common causes help guide this differentiation.</p>

                <div class="region-comparison">
                    <div class="region-section upper">
                        <div class="region-header">
                            <i class="fas fa-arrow-up"></i>
                            <h4>Upper GI Bleeding</h4>
                            <div class="location">Above the Ligament of Treitz</div>
                        </div>
                        <div class="region-body">
                            <h5>Common Causes</h5>
                            <ul>
                                <li><i class="fas fa-circle"></i> <strong>Peptic Ulcer Disease (40-50%)</strong> - #1 cause</li>
                                <li><i class="fas fa-circle"></i> <strong>Esophageal/Gastric Varices</strong> - portal HTN</li>
                                <li><i class="fas fa-circle"></i> <strong>Erosive Gastritis</strong> - NSAIDs, alcohol</li>
                                <li><i class="fas fa-circle"></i> <strong>Mallory-Weiss Tear</strong> - forceful vomiting</li>
                                <li><i class="fas fa-circle"></i> <strong>Malignancy</strong> - gastric/esophageal cancer</li>
                            </ul>

                            <h5>Stool Characteristics</h5>
                            <ul>
                                <li><i class="fas fa-tint"></i> <strong>Melena</strong> - black, tarry, foul-smelling stool</li>
                                <li><i class="fas fa-tint"></i> Requires >50-100 mL blood in GI tract</li>
                                <li><i class="fas fa-tint"></i> Blood oxidized by gastric acid and bacteria</li>
                            </ul>

                            <h5>Other Signs</h5>
                            <ul>
                                <li><i class="fas fa-arrow-right"></i> Hematemesis (vomiting blood - bright red or coffee-ground)</li>
                                <li><i class="fas fa-arrow-right"></i> Coffee-ground emesis (partially digested blood)</li>
                                <li><i class="fas fa-arrow-right"></i> Positive NG aspirate for blood</li>
                            </ul>
                        </div>
                    </div>

                    <div class="region-section lower">
                        <div class="region-header">
                            <i class="fas fa-arrow-down"></i>
                            <h4>Lower GI Bleeding</h4>
                            <div class="location">Below the Ligament of Treitz</div>
                        </div>
                        <div class="region-body">
                            <h5>Common Causes</h5>
                            <ul>
                                <li><i class="fas fa-circle"></i> <strong>Diverticulosis (30-40%)</strong> - #1 cause</li>
                                <li><i class="fas fa-circle"></i> <strong>Angiodysplasia</strong> - arteriovenous malformations</li>
                                <li><i class="fas fa-circle"></i> <strong>Colorectal Cancer/Polyps</strong> - occult or overt</li>
                                <li><i class="fas fa-circle"></i> <strong>Hemorrhoids</strong> - most common benign cause</li>
                                <li><i class="fas fa-circle"></i> <strong>IBD</strong> - Crohn's, ulcerative colitis</li>
                            </ul>

                            <h5>Stool Characteristics</h5>
                            <ul>
                                <li><i class="fas fa-tint"></i> <strong>Hematochezia</strong> - bright red blood per rectum</li>
                                <li><i class="fas fa-tint"></i> Blood mixed with or coating stool</li>
                                <li><i class="fas fa-tint"></i> Maroon stool suggests proximal colonic source</li>
                            </ul>

                            <h5>Other Signs</h5>
                            <ul>
                                <li><i class="fas fa-arrow-right"></i> Usually painless (diverticulosis)</li>
                                <li><i class="fas fa-arrow-right"></i> Abdominal pain with IBD, ischemia</li>
                                <li><i class="fas fa-arrow-right"></i> Change in bowel habits may suggest malignancy</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <div class="info-box warning">
                    <div class="info-box-icon">
                        <i class="fas fa-exclamation-triangle"></i>
                    </div>
                    <div class="info-box-content">
                        <h5>Critical: Brisk UGIB Can Cause Hematochezia!</h5>
                        <p>A <strong>massive upper GI bleed</strong> can present with bright red blood per rectum (hematochezia) because blood moves quickly through the GI tract without time for oxidation. If a patient has hematochezia with hemodynamic instability, consider UGIB and place an NG tube or perform upper endoscopy first!</p>
                    </div>
                </div>

                <div class="florencebot-tip" id="tip-massive-ugib">
                    <div class="florencebot-tip-header">
                        <div class="florencebot-tip-icon">
                            <i class="fas fa-lightbulb"></i>
                        </div>
                        <span class="florencebot-tip-label">FlorenceBot Pro Tip</span>
                    </div>
                    <div class="florencebot-tip-title">Massive UGIB Exception</div>
                    <div class="florencebot-tip-content">
                        <strong>Don't assume bright red blood always means lower GI bleeding!</strong> When there's a <strong>brisk upper GI bleed</strong>, blood moves so quickly through the intestines that it doesn't have time to be digested and turn black. The result? Hematochezia (bright red blood per rectum) - which you'd normally associate with LGIB. The key clue: if the patient is <strong>hemodynamically unstable</strong> (hypotensive, tachycardic) with BRBPR, think UGIB first! These patients need an upper endoscopy before colonoscopy. The instability suggests massive bleeding, which is more common from upper sources.
                    </div>
                </div>

                <h3>Melena vs Hematochezia: Key Differences</h3>

                <div class="guide-table-wrapper">
                    <table class="guide-table">
                        <thead>
                            <tr>
                                <th>Characteristic</th>
                                <th>Melena</th>
                                <th>Hematochezia</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Appearance</td>
                                <td>Black, tarry, sticky</td>
                                <td>Bright red, maroon</td>
                            </tr>
                            <tr>
                                <td>Odor</td>
                                <td>Distinctively foul (digested blood)</td>
                                <td>Typical stool odor</td>
                            </tr>
                            <tr>
                                <td>Typical Source</td>
                                <td>Upper GI (proximal to jejunum)</td>
                                <td>Lower GI (colon, rectum)</td>
                            </tr>
                            <tr>
                                <td>Blood Volume Required</td>
                                <td>50-100 mL minimum</td>
                                <td>Variable</td>
                            </tr>
                            <tr>
                                <td>Transit Time</td>
                                <td>8+ hours in GI tract</td>
                                <td>Rapid transit or distal source</td>
                            </tr>
                            <tr>
                                <td>Exception</td>
                                <td>Right-sided colonic bleeding (slow transit)</td>
                                <td>Massive UGIB (rapid transit)</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <div class="info-box nclex">
                    <div class="info-box-icon">
                        <i class="fas fa-graduation-cap"></i>
                    </div>
                    <div class="info-box-content">
                        <h5>NCLEX Alert: Stool Color Clues</h5>
                        <p><strong>Melena = Upper GI</strong> (usually). <strong>Hematochezia = Lower GI</strong> (usually). But remember: massive UGIB can cause hematochezia, and a slow-bleeding right colon lesion can cause melena. Always assess hemodynamic status and consider the clinical picture!</p>
                    </div>
                </div>

                <div class="bottom-line">
                    <p>ðŸŽ¯ Bottom Line: Upper GI bleeds (PUD, varices, Mallory-Weiss) are more common and more dangerous. Lower GI bleeds (diverticulosis, cancer) are usually less acute but still require evaluation. Varices = highest mortality.</p>
                </div>
            </section>

            <!-- Section 3: Assessment & Clinical Signs -->
            <section class="guide-section" id="assessment">
                <div class="section-header">
                    <div class="section-number">3</div>
                    <div class="section-title-group">
                        <h2>Assessment & Hemodynamic Status</h2>
                        <div class="subtitle">Recognizing severity and instability</div>
                    </div>
                </div>

                <p>The initial assessment of a GI bleed patient focuses on <strong>hemodynamic stability</strong>. The severity of bleeding determines the urgency of intervention, resuscitation needs, and timing of endoscopy.</p>

                <div class="symptom-map">
                    <h3>Signs & Symptoms of GI Bleeding</h3>
                    <div class="symptom-grid">
                        <div class="symptom-card">
                            <div class="symptom-icon"><i class="fas fa-tint"></i></div>
                            <h5>Hematemesis</h5>
                            <p>Vomiting blood - bright red (active) or coffee-ground (digested). Indicates UGIB.</p>
                        </div>
                        <div class="symptom-card">
                            <div class="symptom-icon"><i class="fas fa-poop"></i></div>
                            <h5>Melena/Hematochezia</h5>
                            <p>Black tarry stool or bright red blood per rectum. Key to localizing source.</p>
                        </div>
                        <div class="symptom-card">
                            <div class="symptom-icon"><i class="fas fa-heartbeat"></i></div>
                            <h5>Tachycardia</h5>
                            <p>HR > 100 bpm. Early sign of hypovolemia. May be masked by beta-blockers.</p>
                        </div>
                        <div class="symptom-card">
                            <div class="symptom-icon"><i class="fas fa-compress-arrows-alt"></i></div>
                            <h5>Hypotension</h5>
                            <p>SBP < 90 mmHg or drop > 20 mmHg. Indicates significant blood loss (>30%).</p>
                        </div>
                        <div class="symptom-card">
                            <div class="symptom-icon"><i class="fas fa-dizzy"></i></div>
                            <h5>Orthostatic Changes</h5>
                            <p>Dizziness on standing. HR increase >20 or SBP drop >20 = positive.</p>
                        </div>
                        <div class="symptom-card">
                            <div class="symptom-icon"><i class="fas fa-user"></i></div>
                            <h5>Pallor & Diaphoresis</h5>
                            <p>Pale skin, cool extremities, sweating. Signs of hypovolemic shock.</p>
                        </div>
                    </div>
                </div>

                <h3>Hemodynamic Stability Assessment</h3>

                <div class="stability-assessment">
                    <div class="stability-box stable">
                        <div class="stability-header">
                            <i class="fas fa-check-circle"></i>
                            <h4>Hemodynamically Stable</h4>
                        </div>
                        <div class="stability-body">
                            <ul>
                                <li><i class="fas fa-check"></i> Normal vital signs (HR < 100, SBP > 100)</li>
                                <li><i class="fas fa-check"></i> No orthostatic hypotension</li>
                                <li><i class="fas fa-check"></i> Alert and oriented</li>
                                <li><i class="fas fa-check"></i> Adequate urine output (> 0.5 mL/kg/hr)</li>
                                <li><i class="fas fa-check"></i> Warm, well-perfused extremities</li>
                                <li><i class="fas fa-check"></i> <strong>Management:</strong> Admit to floor, endoscopy within 24 hrs</li>
                            </ul>
                        </div>
                    </div>

                    <div class="stability-box unstable">
                        <div class="stability-header">
                            <i class="fas fa-exclamation-circle"></i>
                            <h4>Hemodynamically Unstable</h4>
                        </div>
                        <div class="stability-body">
                            <ul>
                                <li><i class="fas fa-times"></i> Tachycardia (HR > 100) or hypotension (SBP < 90)</li>
                                <li><i class="fas fa-times"></i> Positive orthostatic changes</li>
                                <li><i class="fas fa-times"></i> Altered mental status, confusion</li>
                                <li><i class="fas fa-times"></i> Oliguria (< 0.5 mL/kg/hr)</li>
                                <li><i class="fas fa-times"></i> Cool, clammy, mottled extremities</li>
                                <li><i class="fas fa-times"></i> <strong>Management:</strong> ICU, emergent endoscopy, massive transfusion protocol</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <h3>Estimating Blood Loss</h3>

                <div class="guide-table-wrapper">
                    <table class="guide-table">
                        <thead>
                            <tr>
                                <th>Class</th>
                                <th>Blood Loss</th>
                                <th>Heart Rate</th>
                                <th>Blood Pressure</th>
                                <th>Mental Status</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Class I</td>
                                <td>< 15% (< 750 mL)</td>
                                <td>< 100</td>
                                <td>Normal</td>
                                <td>Slightly anxious</td>
                            </tr>
                            <tr>
                                <td>Class II</td>
                                <td>15-30% (750-1500 mL)</td>
                                <td>100-120</td>
                                <td>Normal</td>
                                <td>Mildly anxious</td>
                            </tr>
                            <tr>
                                <td>Class III</td>
                                <td>30-40% (1500-2000 mL)</td>
                                <td>120-140</td>
                                <td>Decreased</td>
                                <td>Anxious, confused</td>
                            </tr>
                            <tr>
                                <td>Class IV</td>
                                <td>> 40% (> 2000 mL)</td>
                                <td>> 140</td>
                                <td>Severely decreased</td>
                                <td>Confused, lethargic</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <div class="info-box clinical">
                    <div class="info-box-icon">
                        <i class="fas fa-lightbulb"></i>
                    </div>
                    <div class="info-box-content">
                        <h5>Clinical Pearl: Initial Hemoglobin Can Be Misleading!</h5>
                        <p>In acute GI bleeding, the <strong>initial hemoglobin may be normal</strong> because both red cells and plasma are lost proportionally. Hemodilution from fluid resuscitation and equilibration takes 24-72 hours. A "normal" initial Hgb in an unstable patient does NOT rule out significant bleeding!</p>
                    </div>
                </div>

                <div class="florencebot-tip" id="tip-hgb-misleading">
                    <div class="florencebot-tip-header">
                        <div class="florencebot-tip-icon">
                            <i class="fas fa-lightbulb"></i>
                        </div>
                        <span class="florencebot-tip-label">FlorenceBot Pro Tip</span>
                    </div>
                    <div class="florencebot-tip-title">Initial Hgb Misleading</div>
                    <div class="florencebot-tip-content">
                        <strong>Don't be fooled by a "normal" hemoglobin in acute bleeding!</strong> When someone loses blood, they lose both red cells AND plasma in equal proportions - so the concentration (hemoglobin) initially stays the same. It's only after <strong>hemodilution</strong> occurs (from IV fluid resuscitation and the body pulling fluid from tissues) that the hemoglobin drops. This equilibration takes <strong>24-72 hours</strong>. A patient can be bleeding significantly with a normal initial Hgb. Always assess hemodynamic status (heart rate, blood pressure, mental status) rather than relying on the first lab value.
                    </div>
                </div>

                <h3>Risk Stratification: Glasgow-Blatchford Score</h3>

                <p>The Glasgow-Blatchford Score predicts the need for intervention (transfusion, endoscopy, surgery) in UGIB. A score of 0 identifies very low-risk patients who may be candidates for outpatient management.</p>

                <div class="guide-table-wrapper">
                    <table class="guide-table">
                        <thead>
                            <tr>
                                <th>Variable</th>
                                <th>Points</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>BUN 18.2-22.4 mg/dL</td>
                                <td>2</td>
                            </tr>
                            <tr>
                                <td>BUN 22.4-28 mg/dL</td>
                                <td>3</td>
                            </tr>
                            <tr>
                                <td>BUN 28-70 mg/dL</td>
                                <td>4</td>
                            </tr>
                            <tr>
                                <td>BUN > 70 mg/dL</td>
                                <td>6</td>
                            </tr>
                            <tr>
                                <td>Hemoglobin 12-13 g/dL (men) or 10-12 (women)</td>
                                <td>1</td>
                            </tr>
                            <tr>
                                <td>Hemoglobin 10-12 g/dL (men)</td>
                                <td>3</td>
                            </tr>
                            <tr>
                                <td>Hemoglobin < 10 g/dL</td>
                                <td>6</td>
                            </tr>
                            <tr>
                                <td>SBP 100-109 mmHg</td>
                                <td>1</td>
                            </tr>
                            <tr>
                                <td>SBP 90-99 mmHg</td>
                                <td>2</td>
                            </tr>
                            <tr>
                                <td>SBP < 90 mmHg</td>
                                <td>3</td>
                            </tr>
                            <tr>
                                <td>Pulse > 100 bpm</td>
                                <td>1</td>
                            </tr>
                            <tr>
                                <td>Melena present</td>
                                <td>1</td>
                            </tr>
                            <tr>
                                <td>Syncope</td>
                                <td>2</td>
                            </tr>
                            <tr>
                                <td>Hepatic disease</td>
                                <td>2</td>
                            </tr>
                            <tr>
                                <td>Heart failure</td>
                                <td>2</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <div class="bottom-line">
                    <p>ðŸŽ¯ Bottom Line: Hemodynamic status FIRST â€” tachycardia before hypotension. Melena = upper, hematochezia = usually lower. Check orthostatic vitals. Hgb/Hct lag behind â€” don't be reassured by normal values in acute bleeding.</p>
                </div>
            </section>

            <!-- Section 4: Diagnostic Procedures -->
            <section class="guide-section" id="diagnostics">
                <div class="section-header">
                    <div class="section-number">4</div>
                    <div class="section-title-group">
                        <h2>Diagnostic Procedures</h2>
                        <div class="subtitle">Endoscopy and imaging modalities</div>
                    </div>
                </div>

                <p>The diagnostic approach to GI bleeding aims to <strong>identify the bleeding source</strong> and provide therapeutic intervention when possible. Endoscopy is the cornerstone of diagnosis and treatment for both upper and lower GI bleeding.</p>

                <div class="procedure-visual">
                    <h3><i class="fas fa-clock"></i> Endoscopy Timing Guidelines</h3>
                    <div class="procedure-timeline">
                        <div class="procedure-step">
                            <div class="procedure-marker"><i class="fas fa-check"></i></div>
                            <div class="procedure-label">Stable, Low Risk</div>
                            <div class="procedure-desc">Within 24 hours</div>
                        </div>
                        <div class="procedure-step">
                            <div class="procedure-marker"><i class="fas fa-clock"></i></div>
                            <div class="procedure-label">High Risk Features</div>
                            <div class="procedure-desc">Within 12 hours</div>
                        </div>
                        <div class="procedure-step">
                            <div class="procedure-marker"><i class="fas fa-exclamation"></i></div>
                            <div class="procedure-label">Hemodynamically Unstable</div>
                            <div class="procedure-desc">Emergent (after resuscitation)</div>
                        </div>
                        <div class="procedure-step">
                            <div class="procedure-marker"><i class="fas fa-tint"></i></div>
                            <div class="procedure-label">Suspected Variceal Bleed</div>
                            <div class="procedure-desc">Within 12 hours</div>
                        </div>
                    </div>
                </div>

                <h3>Upper GI Endoscopy (EGD)</h3>

                <div class="guide-table-wrapper">
                    <table class="guide-table">
                        <thead>
                            <tr>
                                <th>Aspect</th>
                                <th>Details</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Indication</td>
                                <td>Suspected UGIB (hematemesis, coffee-ground emesis, melena, positive NG aspirate)</td>
                            </tr>
                            <tr>
                                <td>Sensitivity</td>
                                <td>92-98% for identifying bleeding source</td>
                            </tr>
                            <tr>
                                <td>Therapeutic Options</td>
                                <td>Injection therapy, thermal coagulation, hemoclips, band ligation (varices)</td>
                            </tr>
                            <tr>
                                <td>Pre-Procedure</td>
                                <td>NPO, IV access, type & screen, resuscitation, consider erythromycin (gastric emptying)</td>
                            </tr>
                            <tr>
                                <td>Post-Procedure</td>
                                <td>Monitor for rebleeding (H/H q6h), aspiration, perforation</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <h3>Colonoscopy</h3>

                <div class="guide-table-wrapper">
                    <table class="guide-table">
                        <thead>
                            <tr>
                                <th>Aspect</th>
                                <th>Details</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Indication</td>
                                <td>Suspected LGIB (hematochezia) after stabilization</td>
                            </tr>
                            <tr>
                                <td>Timing</td>
                                <td>Within 24 hours of presentation (after bowel prep if possible)</td>
                            </tr>
                            <tr>
                                <td>Challenge</td>
                                <td>Active bleeding obscures visualization; may need urgent/emergent scope without full prep</td>
                            </tr>
                            <tr>
                                <td>Therapeutic Options</td>
                                <td>Clips, thermal coagulation, injection, APC (argon plasma coagulation)</td>
                            </tr>
                            <tr>
                                <td>Diagnostic Yield</td>
                                <td>74-100% with adequate prep; lower with active bleeding</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <h3>Other Diagnostic Modalities</h3>

                <div class="intervention-cards">
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-x-ray"></i></div>
                            <h5>CT Angiography</h5>
                        </div>
                        <p>Non-invasive; detects active bleeding > 0.3-0.5 mL/min. Useful when endoscopy is inconclusive or patient is too unstable. Can guide angiographic intervention.</p>
                    </div>
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-radiation"></i></div>
                            <h5>Tagged RBC Scan</h5>
                        </div>
                        <p>Nuclear medicine study. Detects bleeding rates as low as 0.1 mL/min. Useful for intermittent bleeding. Takes time; not for emergencies.</p>
                    </div>
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-syringe"></i></div>
                            <h5>Angiography</h5>
                        </div>
                        <p>Invasive; requires active bleeding > 0.5-1 mL/min. Allows therapeutic embolization. Reserve for massive bleeding or failed endoscopy.</p>
                    </div>
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-capsules"></i></div>
                            <h5>Capsule Endoscopy</h5>
                        </div>
                        <p>Swallowed camera for small bowel evaluation. Used for obscure GI bleeding when EGD and colonoscopy are negative. Not for acute bleeding.</p>
                    </div>
                </div>

                <div class="info-box nclex">
                    <div class="info-box-icon">
                        <i class="fas fa-graduation-cap"></i>
                    </div>
                    <div class="info-box-content">
                        <h5>NCLEX Alert: NG Tube in GI Bleeding</h5>
                        <p>An NG tube aspirate can help differentiate UGIB from LGIB:</p>
                        <ul>
                            <li><strong>Bloody or coffee-ground aspirate:</strong> Confirms UGIB</li>
                            <li><strong>Clear aspirate:</strong> Does NOT rule out UGIB (bleeding may be beyond pylorus or intermittent)</li>
                            <li><strong>Bilious, non-bloody aspirate:</strong> Makes UGIB unlikely</li>
                        </ul>
                        <p>NG tubes are NOT routinely placed in all GI bleedsâ€”discuss with the team.</p>
                    </div>
                </div>

                <div class="bottom-line">
                    <p>ðŸŽ¯ Bottom Line: EGD is the gold standard for upper GI bleeds (both diagnostic and therapeutic). Colonoscopy for lower GI. NGT lavage localizes the source. Type and crossmatch, CBC, coagulation studies, BMP, lactate for all GI bleeds.</p>
                </div>
            </section>

            <!-- Section 5: Nursing Interventions -->
            <section class="guide-section" id="interventions">
                <div class="section-header">
                    <div class="section-number">5</div>
                    <div class="section-title-group">
                        <h2>Priority Nursing Interventions</h2>
                        <div class="subtitle">Evidence-based management</div>
                    </div>
                </div>

                <p>Nursing care for GI bleeding focuses on <strong>rapid assessment, hemodynamic stabilization, close monitoring, and preparation for diagnostic/therapeutic procedures</strong>. The first hours are critical.</p>

                <h3>Immediate Priorities: ABCs</h3>

                <div class="intervention-cards">
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-wind"></i></div>
                            <h5>Airway Protection</h5>
                        </div>
                        <p>Assess LOC and gag reflex. Massive hematemesis with altered LOC = intubate for airway protection. Position patient on side if vomiting blood.</p>
                    </div>
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-heartbeat"></i></div>
                            <h5>IV Access & Resuscitation</h5>
                        </div>
                        <p><strong>Two large-bore IVs (18G or larger).</strong> Start crystalloid resuscitation (NS or LR). Goal: restore perfusion, SBP > 90, HR < 100.</p>
                    </div>
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-vial"></i></div>
                            <h5>Labs & Blood Bank</h5>
                        </div>
                        <p>Type & crossmatch (2-6 units), CBC, BMP, coags (PT/INR, PTT), LFTs. Send labs STAT. Have blood available before procedure.</p>
                    </div>
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-chart-line"></i></div>
                            <h5>Continuous Monitoring</h5>
                        </div>
                        <p>Cardiac monitor, pulse ox, BP q15min if unstable. Foley catheter for strict I&O. Goal UOP > 0.5 mL/kg/hr.</p>
                    </div>
                </div>

                <div class="florencebot-tip" id="tip-goal-uop">
                    <div class="florencebot-tip-header">
                        <div class="florencebot-tip-icon">
                            <i class="fas fa-lightbulb"></i>
                        </div>
                        <span class="florencebot-tip-label">FlorenceBot Pro Tip</span>
                    </div>
                    <div class="florencebot-tip-title">Goal UOP</div>
                    <div class="florencebot-tip-content">
                        <strong>Urine output is your best real-time indicator of organ perfusion!</strong> In a bleeding patient, aim for urine output greater than <strong>0.5 mL/kg/hr</strong> (for a 70kg patient, that's about 35 mL/hour or more). Why is this important? The kidneys are very sensitive to blood flow - when cardiac output drops from blood loss, the kidneys are among the first organs to show decreased perfusion. If urine output drops below this threshold (<strong>oliguria</strong>), it signals inadequate resuscitation. Place a Foley catheter for accurate hourly monitoring and document strictly. Trending urine output helps guide fluid and blood product administration.
                    </div>
                </div>

                <h3>Blood Product Administration</h3>

                <div class="guide-table-wrapper">
                    <table class="guide-table">
                        <thead>
                            <tr>
                                <th>Product</th>
                                <th>Trigger/Indication</th>
                                <th>Goal</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>PRBCs</strong></td>
                                <td>Hgb < 7 g/dL (or < 8-9 if CAD, symptomatic)</td>
                                <td>Hgb 7-9 g/dL (restrictive strategy preferred)</td>
                            </tr>
                            <tr>
                                <td><strong>Fresh Frozen Plasma</strong></td>
                                <td>INR > 1.5-2.0, active bleeding</td>
                                <td>INR < 1.5</td>
                            </tr>
                            <tr>
                                <td><strong>Platelets</strong></td>
                                <td>Plt < 50,000 with active bleeding</td>
                                <td>Plt > 50,000</td>
                            </tr>
                            <tr>
                                <td><strong>Massive Transfusion Protocol</strong></td>
                                <td>Expected > 10 units PRBCs in 24h</td>
                                <td>1:1:1 ratio (PRBC:FFP:Plt)</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <div class="info-box tip">
                    <div class="info-box-icon">
                        <i class="fas fa-lightbulb"></i>
                    </div>
                    <div class="info-box-content">
                        <h5>Clinical Pearl: Restrictive Transfusion Strategy</h5>
                        <p>Studies show that a <strong>restrictive transfusion strategy (Hgb trigger 7 g/dL)</strong> is associated with improved outcomes in GI bleeding compared to liberal transfusion. Over-transfusion in variceal bleeding can increase portal pressure and worsen bleeding.</p>
                    </div>
                </div>

                <div class="florencebot-tip" id="tip-restrictive-transfusion">
                    <div class="florencebot-tip-header">
                        <div class="florencebot-tip-icon">
                            <i class="fas fa-lightbulb"></i>
                        </div>
                        <span class="florencebot-tip-label">FlorenceBot Pro Tip</span>
                    </div>
                    <div class="florencebot-tip-title">Restrictive Transfusion</div>
                    <div class="florencebot-tip-content">
                        <strong>Less is more when it comes to blood transfusions in GI bleeding!</strong> Research shows that a <strong>restrictive transfusion strategy</strong> (transfusing when hemoglobin drops below 7 g/dL) actually leads to better patient outcomes than giving blood more liberally. Why? Over-transfusion can increase blood volume and, in patients with variceal bleeding from liver cirrhosis, this raises <strong>portal pressure</strong> and can make the bleeding worse. Exception: patients with coronary artery disease or symptomatic anemia may need a higher threshold (8-9 g/dL). Always follow your institution's protocol.
                    </div>
                </div>

                <h3>Monitoring & Documentation</h3>

                <ul>
                    <li><strong>Vital signs:</strong> q15min if unstable, q1h when stable. Note trends.</li>
                    <li><strong>Serial H/H:</strong> q6h for active bleeding; remember initial values may be misleading</li>
                    <li><strong>I&O:</strong> Strict monitoring. Track all blood product administration.</li>
                    <li><strong>Stool output:</strong> Document color, consistency, frequency, estimated volume</li>
                    <li><strong>Neuro checks:</strong> Monitor for changes indicating worsening perfusion</li>
                    <li><strong>Signs of rebleeding:</strong> Fresh hematemesis, increasing melena/hematochezia, dropping H/H, hemodynamic changes</li>
                </ul>

                <div class="info-box warning">
                    <div class="info-box-icon">
                        <i class="fas fa-exclamation-triangle"></i>
                    </div>
                    <div class="info-box-content">
                        <h5>Signs of Rebleeding - Notify MD Immediately!</h5>
                        <ul>
                            <li>Fresh hematemesis or increased melena/hematochezia</li>
                            <li>Drop in Hgb > 2 g/dL despite transfusion</li>
                            <li>Hemodynamic instability (tachycardia, hypotension)</li>
                            <li>Increased transfusion requirements</li>
                            <li>Change in mental status</li>
                        </ul>
                    </div>
                </div>

                <h3>Special Considerations</h3>

                <div class="intervention-cards">
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-liver"></i></div>
                            <h5>Variceal Bleeding</h5>
                        </div>
                        <p>Start octreotide infusion. Prophylactic antibiotics (ceftriaxone). Prepare for emergent EGD with band ligation. Have balloon tamponade ready.</p>
                    </div>
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-pills"></i></div>
                            <h5>Anticoagulation Reversal</h5>
                        </div>
                        <p>Warfarin: Vitamin K + FFP or 4-factor PCC. DOACs: consider reversal agents (idarucizumab for dabigatran, andexanet for Xa inhibitors).</p>
                    </div>
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-utensils"></i></div>
                            <h5>NPO Status</h5>
                        </div>
                        <p>Keep patient NPO in preparation for endoscopy. Clear liquids may resume after successful procedure if no rebleeding.</p>
                    </div>
                    <div class="intervention-card">
                        <div class="intervention-card-header">
                            <div class="intervention-icon"><i class="fas fa-head-side-virus"></i></div>
                            <h5>Hepatic Encephalopathy Prevention</h5>
                        </div>
                        <p>In cirrhotics: blood in GI tract = protein load = ammonia. Start lactulose. Monitor mental status closely.</p>
                    </div>
                </div>

                <div class="bottom-line">
                    <p>ðŸŽ¯ Bottom Line: ABCs first, then 2 large-bore IVs, aggressive fluid resuscitation, blood transfusion (crossmatched preferred, O-neg if emergent), NPO status, and prepare for endoscopy. For varices: octreotide + emergency EGD with banding.</p>
                </div>
            </section>

            <!-- Section 6: Pharmacology -->
            <section class="guide-section" id="medications">
                <div class="section-header">
                    <div class="section-number">6</div>
                    <div class="section-title-group">
                        <h2>Pharmacological Management</h2>
                        <div class="subtitle">Key medications in GI bleeding</div>
                    </div>
                </div>

                <h3>Proton Pump Inhibitors (PPIs)</h3>

                <div class="guide-table-wrapper">
                    <table class="guide-table">
                        <thead>
                            <tr>
                                <th>Drug</th>
                                <th>Dose</th>
                                <th>Key Points</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>Pantoprazole (Protonix)</strong></td>
                                <td>80 mg IV bolus, then 8 mg/hr infusion x 72h</td>
                                <td>High-dose for high-risk ulcer stigmata; promotes clot stability</td>
                            </tr>
                            <tr>
                                <td><strong>Esomeprazole (Nexium)</strong></td>
                                <td>80 mg IV bolus, then 8 mg/hr infusion</td>
                                <td>Alternative to pantoprazole; same high-dose regimen</td>
                            </tr>
                            <tr>
                                <td><strong>Oral PPI</strong></td>
                                <td>40-80 mg BID after endoscopy</td>
                                <td>Transition to oral after initial IV therapy; continue 6-8 weeks</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <div class="info-box nclex">
                    <div class="info-box-icon">
                        <i class="fas fa-graduation-cap"></i>
                    </div>
                    <div class="info-box-content">
                        <h5>NCLEX Alert: Why High-Dose PPI?</h5>
                        <p>Gastric acid dissolves blood clots. Raising gastric pH > 6 with high-dose PPI stabilizes clots and reduces rebleeding. <strong>High-dose IV PPI is indicated for high-risk ulcers</strong> (active bleeding, visible vessel, adherent clot). Low-risk ulcers may only need oral PPI.</p>
                    </div>
                </div>

                <h3>Vasoactive Medications (for Variceal Bleeding)</h3>

                <div class="guide-table-wrapper">
                    <table class="guide-table">
                        <thead>
                            <tr>
                                <th>Drug</th>
                                <th>Dose</th>
                                <th>Mechanism & Nursing Considerations</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>Octreotide (Sandostatin)</strong></td>
                                <td>50 mcg IV bolus, then 50 mcg/hr infusion x 3-5 days</td>
                                <td>Decreases splanchnic blood flow, reduces portal pressure. First-line for variceal bleed. Monitor glucose (can cause hyper/hypoglycemia).</td>
                            </tr>
                            <tr>
                                <td><strong>Vasopressin</strong></td>
                                <td>0.2-0.4 units/min IV</td>
                                <td>Potent splanchnic vasoconstrictor. Causes coronary vasoconstrictionâ€”use with nitroglycerin. Largely replaced by octreotide.</td>
                            </tr>
                            <tr>
                                <td><strong>Terlipressin</strong></td>
                                <td>2 mg IV q4h initially</td>
                                <td>Vasopressin analog with fewer side effects. Not available in US. Used in Europe.</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <h3>Other Important Medications</h3>

                <div class="guide-table-wrapper">
                    <table class="guide-table">
                        <thead>
                            <tr>
                                <th>Drug</th>
                                <th>Use in GI Bleeding</th>
                                <th>Nursing Considerations</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>Erythromycin</strong></td>
                                <td>250 mg IV 30-120 min before EGD</td>
                                <td>Prokinetic - improves gastric emptying and visualization. Give if significant blood in stomach.</td>
                            </tr>
                            <tr>
                                <td><strong>Antibiotics (cirrhosis)</strong></td>
                                <td>Ceftriaxone 1g IV daily x 7 days</td>
                                <td>Prophylaxis in cirrhotic patients with GI bleed. Reduces infections and mortality.</td>
                            </tr>
                            <tr>
                                <td><strong>Lactulose</strong></td>
                                <td>30-45 mL PO/NG q1h until bowel movement</td>
                                <td>Prevents hepatic encephalopathy from blood protein load in cirrhotics.</td>
                            </tr>
                            <tr>
                                <td><strong>Vitamin K</strong></td>
                                <td>10 mg IV/PO</td>
                                <td>For warfarin reversal. Takes 6-24 hours to work; use with FFP for immediate reversal.</td>
                            </tr>
                            <tr>
                                <td><strong>Tranexamic Acid (TXA)</strong></td>
                                <td>1g IV</td>
                                <td>Antifibrinolytic. Recent trials (HALT-IT) showed no mortality benefit in GI bleeding; not routinely recommended.</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <h3>Medications to Hold or Avoid</h3>

                <div class="info-box warning">
                    <div class="info-box-icon">
                        <i class="fas fa-ban"></i>
                    </div>
                    <div class="info-box-content">
                        <h5>Stop or Hold These Medications!</h5>
                        <ul>
                            <li><strong>Anticoagulants:</strong> Warfarin, heparin, DOACs - reverse if life-threatening bleeding</li>
                            <li><strong>Antiplatelet agents:</strong> Aspirin, clopidogrel - hold unless cardiac stent within 30 days</li>
                            <li><strong>NSAIDs:</strong> Ibuprofen, naproxen - major risk factor for peptic ulcer bleeding</li>
                            <li><strong>Beta-blockers:</strong> May mask tachycardia response to hypovolemia (don't stop abruptly)</li>
                        </ul>
                        <p>Always weigh bleeding risk vs. thrombotic risk with the medical team!</p>
                    </div>
                </div>

                <div class="florencebot-tip" id="tip-hold-anticoagulants">
                    <div class="florencebot-tip-header">
                        <div class="florencebot-tip-icon">
                            <i class="fas fa-lightbulb"></i>
                        </div>
                        <span class="florencebot-tip-label">FlorenceBot Pro Tip</span>
                    </div>
                    <div class="florencebot-tip-title">Hold Anticoagulants</div>
                    <div class="florencebot-tip-content">
                        <strong>Stop the blood thinners - but it's not always simple!</strong> In active GI bleeding, hold anticoagulants (warfarin, heparin, DOACs like rivaroxaban, apixaban) and antiplatelet agents (aspirin, clopidogrel). For life-threatening bleeding, consider reversal: <strong>Vitamin K + FFP</strong> (or 4-factor PCC) for warfarin, <strong>idarucizumab</strong> for dabigatran, <strong>andexanet alfa</strong> for Xa inhibitors. But here's the tricky part: these patients are often on blood thinners for a reason (atrial fibrillation, mechanical valve, recent stent). You're trading bleeding risk for clotting risk. <strong>Always discuss with the medical team</strong> to weigh the risks - especially if the patient had a cardiac stent within 30 days.
                    </div>
                </div>

                <div class="bottom-line">
                    <p>ðŸŽ¯ Bottom Line: PPIs (IV pantoprazole) for peptic ulcer bleeds. Octreotide (Sandostatin) for variceal bleeds (reduces portal pressure). Vasopressin for refractory bleeding. Vitamin K and FFP to correct coagulopathy.</p>
                </div>
            </section>

            <!-- Practice Questions -->
            <section class="practice-questions" id="practice-questions">
                <h2><i class="fas fa-flask"></i> NCLEX Challenge â€” Test Your Knowledge</h2>
                <div class="quiz-cta-box">
                    <div class="quiz-cta-icon"><i class="fas fa-clipboard-check"></i></div>
                    <div class="quiz-cta-content">
                        <h3>Ready to Test Your Knowledge?</h3>
                        <p>10 NCLEX-style questions with detailed rationales covering upper vs lower GI bleed differentiation, hemorrhagic shock classification, transfusion triggers, initial hemoglobin pitfall, NG tube lavage interpretation, and priority interventions. Available in Practice Mode (instant feedback) and Exam Mode (timed, no peeking).</p>
                        <div class="quiz-cta-stats">
                            <span><i class="fas fa-question-circle"></i> 10 Questions</span>
                            <span><i class="fas fa-clock"></i> ~15 min</span>
                            <span><i class="fas fa-layer-group"></i> 3 Question Types</span>
                        </div>
                    </div>
                    <a href="quiz/quiz.html?topic=gi-bleeding" class="quiz-cta-button">
                        <i class="fas fa-play"></i> Start Quiz
                    </a>
                </div>
            </section>

            <!-- Key Points Summary -->
            <section class="key-points-summary">
                <h2><i class="fas fa-star"></i> Key Takeaways</h2>
                <div class="key-points-list">
                    <div class="key-point-item">
                        <i class="fas fa-map-marker-alt"></i>
                        <p><strong>Ligament of Treitz:</strong> The dividing line. Above = UGIB. Below = LGIB. Critical for determining workup.</p>
                    </div>
                    <div class="key-point-item">
                        <i class="fas fa-poop"></i>
                        <p><strong>Stool Clues:</strong> Melena = usually UGIB. Hematochezia = usually LGIB. But massive UGIB can cause hematochezia!</p>
                    </div>
                    <div class="key-point-item">
                        <i class="fas fa-heartbeat"></i>
                        <p><strong>Hemodynamic Status:</strong> Unstable = emergent intervention. Stable = endoscopy within 24 hours.</p>
                    </div>
                    <div class="key-point-item">
                        <i class="fas fa-syringe"></i>
                        <p><strong>Large-bore IV Access:</strong> Two 18G or larger IVs. Type & crossmatch. Be ready for massive transfusion.</p>
                    </div>
                    <div class="key-point-item">
                        <i class="fas fa-tint"></i>
                        <p><strong>Transfusion:</strong> Restrictive strategy preferred (Hgb trigger 7 g/dL). Initial Hgb may be misleading!</p>
                    </div>
                    <div class="key-point-item">
                        <i class="fas fa-pills"></i>
                        <p><strong>High-dose PPI:</strong> 80 mg bolus + 8 mg/hr infusion for high-risk peptic ulcer bleeding to stabilize clots.</p>
                    </div>
                </div>
            </section>

            <!-- Cross-References -->
            <section class="cross-references" id="cross-references">
                <h2><i class="fas fa-book-open"></i> Related Guides in the Library</h2>
                <div class="cross-ref-group">
                    <h3>Before this guide, review:</h3>
                    <ul>
                        <li><a href="assessment-skills.html"><i class="fas fa-arrow-right"></i> Assessment Skills</a></li>
                    </ul>
                </div>
                <div class="cross-ref-group">
                    <h3>After this guide, study:</h3>
                    <ul>
                        <li><span class="coming-soon"><i class="fas fa-clock"></i> Liver Disease â€” Coming Soon</span></li>
                        <li><span class="coming-soon"><i class="fas fa-clock"></i> Bowel Obstruction â€” Coming Soon</span></li>
                    </ul>
                </div>
                <div class="cross-ref-group">
                    <h3>Also relevant:</h3>
                    <ul>
                        <li><span class="coming-soon"><i class="fas fa-clock"></i> Fluid & Electrolytes â€” Coming Soon</span></li>
                    </ul>
                </div>
            </section>

        </div>

        <!-- Document Footer -->
        <div class="document-footer">
            <img src="../assets/images/the-nursing-collective-logo.webp" alt="The Nursing Collective" class="footer-logo">
            <p class="footer-tagline">Empowering nursing students with evidence-based study resources</p>
            <p class="footer-copyright">&copy; 2026 The Nursing Collective. All rights reserved.</p>
        </div>

    </div>

    <!-- Guide page scripts (external for CSP compliance) -->
    <script src="configs/gi-bleeding-config.js"></script>
    <script src="guide-sidebar.js"></script>
    <script src="guide-script.js"></script>
    <script src="../content-gate.js"></script>
</body>
</html>
